September 16, 2013
Pharmaceutical giant Warner Chilcott PLC was hit with a putative class action Monday in Pennsylvania federal court alleging it unfairly raised the price of its oral contraceptive Loestrin and stifled competition by paying generic-drug makers Actavis Inc. and Lupin Ltd. to drop their patent challenges.